Severity
Moderate
FDA Drug recall · Reported April 20, 2022
Out of specification results observed in dissolution during long term stability testing.
Preferred Pharmaceuticals, Inc. recalled Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release C… - a moderate-severity action.
Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release C… was recalled by Preferred Pharmaceuticals, Inc. in April 20, 2022. Reason: Out of specification results observed in dissolution during long term stability testing.. Check the official notice for the remedy. Verify recall #D-0769-2022 with the FDA Drug before acting.
The recall
Preferred Pharmaceuticals, Inc. issued this moderate-severity FDA Drug recall-Out of specification results observed in dissolution during long term stability testing..
Sourced from official FDA Drug enforcement records. Verify recall #D-0769-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0769-2022) was formally reported on April 20, 2022, with the manufacturer initiating the action on March 28, 2022. It is classified under Moderate severity (Class II), with a current status of Terminated. Preferred Pharmaceuticals, Inc. is listed as the recalling firm, operating out of Anaheim, CA. Federal records list the affected scope as 791 bottles of 90 - Count.
The documented reason for this recall is: Out of specification results observed in dissolution during long term stability testing. Distribution data in the federal record shows the product reached: Nationwide in the USA and CA.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 3,731 children & baby products recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
791 bottles of 90 - Count
Related Recalls
6
0 from same agency
Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release Capsules, 15mg, Generic for Prevacid, 90-Count Bottle, Manufacturer: Dr Reddy's Laboratories Limited, NDC 68788-6390-09
Out of specification results observed in dissolution during long term stability testing.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0769-2022 |
| Date reported | April 20, 2022 |
| Date initiated | March 28, 2022 |
| Recalling firm | Preferred Pharmaceuticals, Inc. |
| Firm location | Anaheim, CA |
| Affected scope | 791 bottles of 90 - Count |
| Distribution | Nationwide in the USA and CA. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Xishentang Dongguan Trading Co, Ltd., dba Pretty-Life, of China · 2026-07-02
Diamond Wipes International, Inc. of Chino, California · 2026-07-02
· 2026-07-02
· 2026-07-02
Sanven Technology Ltd., dba Vevor, of Rancho Cucamonga, California · 2026-07-02
Compare this recall with AMASKY Nursing Pillows Recalled Due to Risk of Serious Inju… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported April 20, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.